Diamyd Medical AB
Djurgårdsbrunnsv.54
Stockholm
S-115 25
Tel: 46-8-661-00-26
Website: http://www.diamyd.com/
Email: info@diamyd.com
145 articles about Diamyd Medical AB
-
Information about Summons to the Annual General Meeting of Diamyd Medical AB
11/8/2011
-
Diamyd Medical AB: Financial Statement 10/11
10/13/2011
-
Diamyd Medical AB Awarded Three Million Dollar Grant and Expands the NTTDS Portfolio
9/12/2011
-
Diamyd Medical AB: Diamyd Puts Focus on Pain Projects and Reduces Costs
8/17/2011
-
Diamyd Medical AB Appoints Peter Zerhouni as President
7/6/2011
-
Diamyd Medical AB: Quarterly Report III 10/11
7/1/2011
-
Diamyd Medical AB Increases Shareholding in Protein Sciences Corporation
6/30/2011
-
Diamyd Medical AB TrialNet Presents Results From a Study with Diamyd(R)
6/28/2011
-
Diamyd Medical AB Discontinues US Phase III Trial with Type I Diabetes Product
6/24/2011
-
Ortho-McNeil Pharmaceutical, Inc. Ditches $625 Million Diabetes Drug Pact with Diamyd Medical AB
6/2/2011
-
Diamyd Medical AB Closes European Phase III Study After Trial Failure
6/1/2011
-
Diamyd Medical AB Replaces CEO
4/26/2011
-
Diamyd Medical AB Quarterly Report II 10/11
4/14/2011
-
Publication of Change in the Total Number of Shares and Votes in Diamyd Medical AB
2/28/2011
-
Publication of Change in the Total Number of Shares and Votes in Diamyd Medical AB
2/28/2011
-
Diamyd Medical AB: Last Patient Completes the EU Phase III Study of Diamyd(R) Antigen Based Therapy for Type 1 Diabetes
2/14/2011
-
Diamyd Medical AB Starts Phase II Study in Cancer Pain
1/18/2011
-
Publication of Change in the Total Number of Shares and Votes in Diamyd Medical AB
12/30/2010
-
Diamyd Medical AB to NASDAQ OMX Stockholm Mid Cap
12/17/2010
-
Diamyd Medical AB: Annual Report 09/10
12/16/2010